MC

Morningside Capital

North America, Illinois, United States, Chicago

Description

Morningside Capital is a venture capital and private equity company that specializes in early-stage investing.

Investor Profile

Morningside Capital has made 3 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Angel (33%)
  • Series A (33%)
  • Series C (33%)

Country Focus

  • China (67%)
  • United States (33%)

Industry Focus

  • Packaging Services
  • Semiconductor
  • Artificial Intelligence (Ai)
  • Biotechnology
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Morningside Capital frequently co-invest with?

SI
Asia, Jiangsu, China, Xishan
Co-Investments: 1
CL
Asia, Beijing, China, Beijing
Co-Investments: 1
CITIC Capital Holdings
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1
Guoce Group
Asia, Beijing, China, Beijing
Co-Investments: 1
Long Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Co-Investments: 1
5Y Capital
Asia, Shanghai, China, Xuhui
Co-Investments: 1
HN
Asia, Beijing, China, Beijing
Co-Investments: 1
Huaye Tiancheng Capital
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
Co-Investments: 1

What are some of recent deals done by Morningside Capital?

Xinde Semiconductor

Nanjing, Jiangsu, China

Xinde Semiconductor offers services for semiconductor packaging and testing.

Packaging ServicesSemiconductor
Series AAug 1, 2021
Xinde Semiconductor

Nanjing, Jiangsu, China

Xinde Semiconductor offers services for semiconductor packaging and testing.

Packaging ServicesSemiconductor
AngelJan 1, 2021
XtalPi

Cambridge, Massachusetts, United States

XtalPi is a pharmaceutical technology company that is reinventing drug discovery by enabling dry lab predictions with wet lab validation.

Artificial Intelligence (AI)BiotechnologyPharmaceutical
Series CSep 28, 2020
Amount Raised: $318,800,000